HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

A Myeloma Caregiver’s Journey: Barb Mower’s Practical Insights and Hard-Earned Advice

November 19, 2024

Learn from Barb Mower's experience as she navigated the difficult and often lonely diagnosis of her husband, Chip.

How to Truly Help Blood Cancer Caregivers and What to Possibly Avoid

November 18, 2024

Blood cancer caregivers shared community support tips. Learn how you can help and what to reconsider before acting.

Philadelphia’s Role in Biotech Innovation - Alongside Myeloma Coaches

November 16, 2024

Myeloma coaches participated in the third annual Philly Builds Bio conference earlier this year.

What Is the Best Consolidation/Maintenance Therapy for People with Myeloma?

November 15, 2024

Learn about what consolidation and maintenance therapy are in myeloma and how it can be personalized for your benefit.

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and More

November 15, 2024

Learn insights about how to manage the many different responsibilities that come with a blood cancer caregiver role.

Myeloma Treatments that Target the Microenvironment

November 14, 2024

Learn about the microenvironment and how certain treatments target myeloma cells' interaction with the cells around them.

New Treatment Coming for High-Risk Smoldering Myeloma?

November 12, 2024

Johnson & Johnson seeks FDA and EMA approval for Darzalex Faspro in high-risk smoldering myeloma, aiming to change the treatment paradigms.

How Myeloma Induction Therapy Is Evolving: Vital Insights for Newly Diagnosed Patients

November 07, 2024

Learn what newly diagnosed multiple myeloma patients need to know about how induction (starting) therapy is evolving in the myeloma treatment landscape.